Cefotetan Articles
Abraxis gains expedited appro of generic cefotetan
20 August 2007
Zeneca Sees Strong Growth Against The Odds
8 August 1997
Strong Fundamentals On Show At Zeneca
19 August 1996
Independent Position To Be Maintained At Zeneca
18 March 1996
Zeneca Gets First Full Approval For Merrem
5 September 1994
ZENECA GETS ANALYST UPGRADING
11 July 1994
ZENECA LICENSES DRUGS TO VHA INC
13 June 1994
Showing 1-8 of 8 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- New Zealand declines Alexion's funding application for Solaris
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
